The Need for New Donor Stratification to Predict Graft Survival in Deceased Donor Kidney Transplantation.
10.3349/ymj.2017.58.3.626
- Author:
Shin Seok YANG
1
;
Jaeseok YANG
;
Curie AHN
;
Sang Il MIN
;
Jongwon HA
;
Sung Joo KIM
;
Jae Berm PARK
Author Information
1. Department of Surgery, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea.
- Publication Type:Original Article
- Keywords:
Kidney transplantation;
deceased donor;
standard criteria donor;
expanded criteria donor;
allocation
- MeSH:
Cold Ischemia;
Follow-Up Studies;
Glomerular Filtration Rate;
Graft Survival*;
Humans;
Kidney Transplantation*;
Kidney*;
Male;
Multivariate Analysis;
Retrospective Studies;
Risk Factors;
Tissue Donors*;
Transplant Recipients;
Transplants*
- From:Yonsei Medical Journal
2017;58(3):626-630
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The aim of this study was to determine whether stratification of deceased donors by the United Network for Organ Sharing (UNOS) criteria negatively impacts graft survival. MATERIALS AND METHODS: We retrospectively reviewed deceased donor and recipient pretransplant variables of kidney transplantations that occurred between February 1995 and December 2009. We compared clinical outcomes between standard criteria donors (SCDs) and expanded criteria donors (ECDs). RESULTS: The deceased donors consisted of 369 patients. A total of 494 transplant recipients were enrolled in this study. Mean age was 41.7±11.4 year (range 18–69) and 273 patients (55.4%) were male. Mean duration of follow-up was 8.8±4.9 years. The recipients from ECD kidneys were 63 patients (12.8%). The overall mean cold ischemia time was 5.7±3.2 hours. Estimated glomerular filtration rate at 1, 2, and 3 years after transplantation were significantly lower in ECD transplants (1 year, 62.2±17.6 vs. 51.0±16.4, p<0.001; 2 year, 62.2±17.6 vs. 51.0±16.4, p=0.001; 3 year, 60.9±23.5 vs. 54.1±18.7, p=0.047). In multivariate analysis, donor age (≥40 years) was an independent risk factor for graft failure. In Kaplan-Meier analyses, there was no significant difference in death-censored graft survival (Log rank test, p>0.05), although patient survival was lower in ECDs than SCDs (Log rank test, p=0.011). CONCLUSION: Our data demonstrate that stratification by the UNOS criteria does not predict graft survival. In order to expand the donor pool, new criteria for standard/expanded donors need to be modified by regional differences.
